The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria

  • Choi, Won-Sun (Department of Allergy and Clinical Immunology, Ajou University School of Medicine) ;
  • Lim, Eun-Soo (Department of Allergy and Clinical Immunology, Ajou University School of Medicine) ;
  • Ban, Ga-Young (Department of Allergy and Clinical Immunology, Ajou University School of Medicine) ;
  • Kim, Ji-Hye (Department of Allergy and Clinical Immunology, Ajou University School of Medicine) ;
  • Shin, Yoo-Seob (Department of Allergy and Clinical Immunology, Ajou University School of Medicine) ;
  • Park, Hae-Sim (Department of Allergy and Clinical Immunology, Ajou University School of Medicine) ;
  • Ye, Young-Min (Department of Allergy and Clinical Immunology, Ajou University School of Medicine)
  • Received : 2015.06.29
  • Accepted : 2015.09.17
  • Published : 2018.01.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Chronic urticaria (CU) is a common skin disorder characterized by wheals and pruritus lasting more than 6 weeks. Due to its long duration and changeable symptoms, the quality of life (QOL) of patients with CU can be impaired substantially. We evaluated the CU-QOL, a previously validated CU-specific QOL measure, and investigated factors influencing QOL in chronic spontaneous urticaria (CSU) patients. Methods: A hospital-based cross-sectional study was performed on 390 adult patients diagnosed with CSU from March 2009 to December 2012 at the Allergy and Clinical Immunology Clinic at Ajou University Hospital. The CU-QOL questionnaire, urticaria activity score (UAS), combined angioedema, and serum total immunoglobulin E (IgE) levels were investigated. Results: The average CU-QOL score obtained from the questionnaire was 70.6 (of 100 points). The CU-QOL scores correlated significantly with the UAS, particularly with the 15-point UAS (UAS-15; coefficient -0.532, p < 0.01) rather than the 6-point UAS (-0.502, p < 0.01). The patients presenting with angioedema and urticaria had poorer scores in the urticaria symptom domain than those with urticaria alone (37.4 vs. 46.9, p = 0.004). Log-transformed serum total IgE levels correlated significantly with CU-QOL (-0.131, p < 0.05). Multivariate regression models indicated that severe CU (UAS-15 score ${\geq}13$), log (total IgE), and the presence of angioedema were significant predictors of impaired CU-QOL (< 85 points). Conclusions: CU has a substantial negative impact on QOL. The assessment of UAS-15, total IgE, and the presence of angioedema can be useful to predict QOL of the patients with CSU.

Keywords

Acknowledgement

Supported by : National Research Foundation of Korea

References

  1. Ye YM, Jang GC, Choi SH, et al. KAAACI Work Group report on the management of chronic urticaria. Allergy Asthma Respir Dis 2015;3:3-14. https://doi.org/10.4168/aard.2015.3.1.3
  2. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014;69:868-887. https://doi.org/10.1111/all.12313
  3. Saini SS. Chronic spontaneous urticaria: etiology and pathogenesis. Immunol Allergy Clin North Am 2014;34:33-52. https://doi.org/10.1016/j.iac.2013.09.012
  4. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201. https://doi.org/10.1111/j.1365-2133.1997.tb14895.x
  5. Engin B, Uguz F, Yilmaz E, Ozdemir M, Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008;22:36-40.
  6. Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci 1997;14:63-67. https://doi.org/10.1016/S0923-1811(96)00553-1
  7. Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria: a GA(2)LEN task force report. Allergy 2011;66:317-330. https://doi.org/10.1111/j.1398-9995.2010.02496.x
  8. Ozkan M, Oflaz SB, Kocaman N, et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007;99:29-33. https://doi.org/10.1016/S1081-1206(10)60617-5
  9. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005;60:1073-1078. https://doi.org/10.1111/j.1398-9995.2005.00833.x
  10. Ye YM, Park JW, Kim SH, et al. Clinical evaluation of the computerized chronic urticaria-specific quality of life questionnaire in Korean patients with chronic urticaria. Clin Exp Dermatol 2012;37:722-728. https://doi.org/10.1111/j.1365-2230.2012.04414.x
  11. Ye YM, Jin HJ, Hwang EK, et al. Co-existence of chronic urticaria and metabolic syndrome: clinical implications. Acta Derm Venereol 2013;93:156-160. https://doi.org/10.2340/00015555-1443
  12. Weller K, Groffik A, Church MK, et al. Development and validation of the urticaria control test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol 2014;133:1365-1372. https://doi.org/10.1016/j.jaci.2013.12.1076
  13. Baiardini I, Bousquet PJ, Brzoza Z, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010;65:290-295. https://doi.org/10.1111/j.1398-9995.2009.02263.x
  14. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010;35:869-873. https://doi.org/10.1111/j.1365-2230.2010.03840.x
  15. Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004;59:869-873. https://doi.org/10.1111/j.1398-9995.2004.00473.x
  16. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-671. https://doi.org/10.1046/j.1365-2133.1999.02767.x
  17. Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy 2012;67:1289-1298. https://doi.org/10.1111/all.12007
  18. Weller K, Groffik A, Magerl M, et al. Development, validation, and initial results of the angioedema activity score. Allergy 2013;68:1185-1192.
  19. Maurer M, Rosen K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013;368:924-935. https://doi.org/10.1056/NEJMoa1215372
  20. Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res 2012;4:326-331. https://doi.org/10.4168/aair.2012.4.6.326
  21. Nam YH, Kim JH, Jin HJ, et al. Effects of omalizumab treatment in patients with refractory chronic urticaria. Allergy Asthma Immunol Res 2012;4:357-361. https://doi.org/10.4168/aair.2012.4.6.357
  22. Kessel A, Helou W, Bamberger E, et al. Elevated serum total IgE: a potential marker for severe chronic urticaria. Int Arch Allergy Immunol 2010;153:288-293. https://doi.org/10.1159/000314370
  23. Chang TW, Chen C, Lin CJ, Metz M, Church MK, Maurer M. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 2015;135:337-342. https://doi.org/10.1016/j.jaci.2014.04.036
  24. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008;63:777-780. https://doi.org/10.1111/j.1398-9995.2008.01726.x
  25. O'Donnell BF. Urticaria: impact on quality of life and economic cost. Immunol Allergy Clin North Am 2014;34:89-104. https://doi.org/10.1016/j.iac.2013.09.011

Cited by

  1. Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria vol.118, pp.4, 2017, https://doi.org/10.1016/j.anai.2016.12.023
  2. Pattern of chronic urticaria and value of autologous serum skin test in Sohag Province, Upper Egypt vol.10, pp.5, 2018, https://doi.org/10.19082/6781
  3. Therapeutic effect of Bacillus Calmette-Guerin polysaccharide nucleic acid on mast cell at the transcriptional level vol.7, pp.None, 2018, https://doi.org/10.7717/peerj.7404
  4. Educational level and job status are the most important factors affecting compliance with oral antihistamine therapy for patients with chronic urticaria vol.30, pp.2, 2019, https://doi.org/10.1080/09546634.2018.1476651
  5. Antihistamine‐resistant chronic spontaneous urticaria: 1‐year data from the AWARE study vol.49, pp.5, 2018, https://doi.org/10.1111/cea.13309
  6. Urticaria: Classification and Diagnosis vol.94, pp.4, 2018, https://doi.org/10.3904/kjm.2019.94.4.353
  7. The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management vol.12, pp.4, 2020, https://doi.org/10.4168/aair.2020.12.4.563
  8. Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures vol.12, pp.4, 2020, https://doi.org/10.4168/aair.2020.12.4.599
  9. The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria vol.12, pp.5, 2018, https://doi.org/10.4168/aair.2020.12.5.750
  10. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H 1 -Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study vol.13, pp.4, 2018, https://doi.org/10.1016/j.waojou.2020.100117
  11. Anxiety, depression, and stress in Korean patients with chronic urticaria vol.35, pp.6, 2018, https://doi.org/10.3904/kjim.2019.320
  12. Presence of IgE Autoantibodies Against Eosinophil Peroxidase and Eosinophil Cationic Protein in Severe Chronic Spontaneous Urticaria and Atopic Dermatitis vol.13, pp.5, 2021, https://doi.org/10.4168/aair.2021.13.5.746